-
Je něco špatně v tomto záznamu ?
Functional electrical stimulation-assisted cycle ergometry-based progressive mobility programme for mechanically ventilated patients: randomised controlled trial with 6 months follow-up
P. Waldauf, N. Hrušková, B. Blahutova, J. Gojda, T. Urban, A. Krajčová, M. Fric, K. Jiroutková, K. Řasová, F. Duška
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, randomizované kontrolované studie, práce podpořená grantem
Grantová podpora
NV17-28778A
MZ0
CEP - Centrální evidence projektů
NV17-28778A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
ProQuest Central
od 1946-03-01 do Před 6 měsíci
Open Access Digital Library
od 1946-03-01
Health & Medicine (ProQuest)
od 1946-03-01 do Před 6 měsíci
- MeSH
- časové faktory MeSH
- elektrická stimulace MeSH
- ergometrie metody MeSH
- jednotky intenzivní péče * MeSH
- kritický stav rehabilitace MeSH
- kvalita života * MeSH
- lidé středního věku MeSH
- lidé MeSH
- následné studie MeSH
- prospektivní studie MeSH
- svalová síla fyziologie MeSH
- svalová slabost patofyziologie rehabilitace MeSH
- terapie cvičením metody MeSH
- umělé dýchání metody MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
PURPOSE: Functional electrical stimulation-assisted cycle ergometry (FESCE) enables in-bed leg exercise independently of patients' volition. We hypothesised that early use of FESCE-based progressive mobility programme improves physical function in survivors of critical care after 6 months. METHODS: We enrolled mechanically ventilated adults estimated to need >7 days of intensive care unit (ICU) stay into an assessor-blinded single centre randomised controlled trial to receive either FESCE-based protocolised or standard rehabilitation that continued up to day 28 or ICU discharge. RESULTS: We randomised in 1:1 ratio 150 patients (age 61±15 years, Acute Physiology and Chronic Health Evaluation II 21±7) at a median of 21 (IQR 19-43) hours after admission to ICU. Mean rehabilitation duration of rehabilitation delivered to intervention versus control group was 82 (IQR 66-97) versus 53 (IQR 50-57) min per treatment day, p<0.001. At 6 months 42 (56%) and 46 (61%) patients in interventional and control groups, respectively, were alive and available to follow-up (81.5% of prespecified sample size). Their Physical Component Summary of SF-36 (primary outcome) was not different at 6 months (50 (IQR 21-69) vs 49 (IQR 26-77); p=0.26). At ICU discharge, there were no differences in the ICU length of stay, functional performance, rectus femoris cross-sectional diameter or muscle power despite the daily nitrogen balance was being 0.6 (95% CI 0.2 to 1.0; p=0.004) gN/m2 less negative in the intervention group. CONCLUSION: Early delivery of FESCE-based protocolised rehabilitation to ICU patients does not improve physical functioning at 6 months in survivors. TRIAL REGISTRATION NUMBER: NCT02864745.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21025501
- 003
- CZ-PrNML
- 005
- 20211026133742.0
- 007
- ta
- 008
- 211013s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/thoraxjnl-2020-215755 $2 doi
- 035 __
- $a (PubMed)33931570
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Waldauf, Petr $u Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic
- 245 10
- $a Functional electrical stimulation-assisted cycle ergometry-based progressive mobility programme for mechanically ventilated patients: randomised controlled trial with 6 months follow-up / $c P. Waldauf, N. Hrušková, B. Blahutova, J. Gojda, T. Urban, A. Krajčová, M. Fric, K. Jiroutková, K. Řasová, F. Duška
- 520 9_
- $a PURPOSE: Functional electrical stimulation-assisted cycle ergometry (FESCE) enables in-bed leg exercise independently of patients' volition. We hypothesised that early use of FESCE-based progressive mobility programme improves physical function in survivors of critical care after 6 months. METHODS: We enrolled mechanically ventilated adults estimated to need >7 days of intensive care unit (ICU) stay into an assessor-blinded single centre randomised controlled trial to receive either FESCE-based protocolised or standard rehabilitation that continued up to day 28 or ICU discharge. RESULTS: We randomised in 1:1 ratio 150 patients (age 61±15 years, Acute Physiology and Chronic Health Evaluation II 21±7) at a median of 21 (IQR 19-43) hours after admission to ICU. Mean rehabilitation duration of rehabilitation delivered to intervention versus control group was 82 (IQR 66-97) versus 53 (IQR 50-57) min per treatment day, p<0.001. At 6 months 42 (56%) and 46 (61%) patients in interventional and control groups, respectively, were alive and available to follow-up (81.5% of prespecified sample size). Their Physical Component Summary of SF-36 (primary outcome) was not different at 6 months (50 (IQR 21-69) vs 49 (IQR 26-77); p=0.26). At ICU discharge, there were no differences in the ICU length of stay, functional performance, rectus femoris cross-sectional diameter or muscle power despite the daily nitrogen balance was being 0.6 (95% CI 0.2 to 1.0; p=0.004) gN/m2 less negative in the intervention group. CONCLUSION: Early delivery of FESCE-based protocolised rehabilitation to ICU patients does not improve physical functioning at 6 months in survivors. TRIAL REGISTRATION NUMBER: NCT02864745.
- 650 _2
- $a kritický stav $x rehabilitace $7 D016638
- 650 _2
- $a elektrická stimulace $7 D004558
- 650 _2
- $a ergometrie $x metody $7 D016552
- 650 _2
- $a terapie cvičením $x metody $7 D005081
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a jednotky intenzivní péče $7 D007362
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a svalová síla $x fyziologie $7 D053580
- 650 _2
- $a svalová slabost $x patofyziologie $x rehabilitace $7 D018908
- 650 _2
- $a prospektivní studie $7 D011446
- 650 12
- $a kvalita života $7 D011788
- 650 _2
- $a umělé dýchání $x metody $7 D012121
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hrušková, Natália $u Department of Rehabilitation, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Blahutova, Barbora $u Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Gojda, Jan $u Department of Internal Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Urban, Tomáš $u Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Krajčová, Adéla $u Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Fric, Michal $u Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Jiroutková, Kateřina $u Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Řasová, Kamila $u Department of Rehabilitation, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Duška, František $u Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic frantisek.duska@lf3.cuni.cz
- 773 0_
- $w MED00004515 $t Thorax $x 1468-3296 $g Roč. 76, č. 7 (2021), s. 664-671
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33931570 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133748 $b ABA008
- 999 __
- $a ok $b bmc $g 1714524 $s 1146008
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 76 $c 7 $d 664-671 $e 20210430 $i 1468-3296 $m Thorax $n Thorax $x MED00004515
- GRA __
- $a NV16-28663A $a NV17-28778A $p MZ0 $p MZ0
- GRA __
- $a NV16-28663A $a NV17-28778A $p MZ0 $p MZ0
- LZP __
- $a Pubmed-20211013